Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 441 entries
View as:

Antithyroid Drugs During Radioiodine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00150137 Org: User:
Start: 01/31/03 End: 12/31/04 Due: 12/31/05

The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05710159 Org: User:
Start: 12/12/22 End: 12/30/24 Due: 12/30/25

The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy

Phase: N/A Priority: Normal
NCT ID: NCT02173418 Org: User:
Start: 11/30/12 End: 07/31/14 Due: 07/31/15

Observational Study of the Prognosis in Treated Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00225030 Org: User:
Start: 01/31/70 End: 07/31/04 Due: 07/31/05

PRISMA-PET - Primary Staging of Prostate Cancer With PSMA

Phase: N/A Priority: Normal
NCT ID: NCT05123300 Org: User:
Start: 10/04/21 End: 01/30/25 Due: 01/30/26

[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00670527 Org: User:
Start: 01/31/08 End: 04/30/13 Due: 04/30/14

The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT

Phase: N/A Priority: Normal
NCT ID: NCT02157350 Org: User:
Start: 08/31/14 End: 09/30/17 Due: 09/30/18

Acupuncture as Treatment of Post-herpetic Neuralgia: A RCT A Double-blinded Randomized Clinical Trial.

Phase: N/A Priority: Normal
NCT ID: NCT03974438 Org: User:
Start: 09/19/19 End: 09/14/20 Due: 09/14/21

Effect Camostat for Kidney Protection in Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06794593 Org: User:
Start: 11/21/24 End: 02/28/27 Due: 02/28/28

Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT05380856 Org: User:
Start: 09/26/23 End: 03/01/27 Due: 03/01/28

CUP Project PET/CT

Phase: N/A Priority: Normal
NCT ID: NCT01469026 Org: User:
Start: 11/30/11 End: 12/31/14 Due: 12/31/15

Navelbine And Radiotherapy in Locally Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00887783 Org: User:
Start: 05/01/09 End: 09/01/16 Due: 09/01/17

Estimation of Intracranial Pressure Using Non-invasive Fundus Videos

Phase: N/A Priority: Normal
NCT ID: NCT03382860 Org: User:
Start: 06/01/17 End: 08/01/25 Due: 08/01/26

Severe Lung Disease in Childhood

Phase: N/A Priority: Normal
NCT ID: NCT06455800 Org: User:
Start: 08/01/24 End: 12/31/40 Due: 12/31/41

Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database

Phase: N/A Priority: Normal
NCT ID: NCT05933330 Org: User:
Start: 04/01/22 End: 07/31/25 Due: 07/31/26

The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06050577 Org: User:
Start: 06/07/24 End: 11/30/25 Due: 11/30/26

S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen

Phase: N/A Priority: Normal
NCT ID: NCT04912076 Org: User:
Start: 09/17/18 End: 03/22/19 Due: 03/22/20

Self-care Behaviour Treatment in Patients With Diabetes - a Randomised Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT00555854 Org: User:
Start: 12/31/05 End: 11/30/10 Due: 11/30/11

Dose-response Effect of Pine Nut Oil as a Dual FFA1 and FFA4 Agonist on Glucose Tolerance in Healthy Humans.

Phase: N/A Priority: Normal
NCT ID: NCT03305367 Org: User:
Start: 02/06/17 End: 08/23/17 Due: 08/23/18

Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT03016637 Org: User:
Start: 01/31/16 End: 12/31/16 Due: 12/31/17

PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT

Phase: N/A Priority: Normal
NCT ID: NCT05615909 Org: User:
Start: 11/19/20 End: 12/31/23 Due: 12/31/24

Individualised Follow-up After Valve Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03053778 Org: User:
Start: 11/01/16 End: 06/02/18 Due: 06/02/19

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01295086 Org: User:
Start: 03/31/11 End: 01/31/18 Due: 01/31/19

Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)

Phase: N/A Priority: Normal
NCT ID: NCT01388244 Org: User:
Start: 02/28/10 End: 12/31/21 Due: 12/31/22

the Type ONe dIabetic Bone Collaboration Study

Phase: N/A Priority: Normal
NCT ID: NCT05673837 Org: User:
Start: 12/10/21 End: 04/01/24 Due: 04/01/25